Redefining the Diagnosis of Type 1 Diabetes

Updated criteria could open new possibilities for intervention before symptoms appear JDRF is leading a pertinent discussion in the diabetes field about what defines a diagnosis of type 1 diabetes (T1D). At the 14th Annual Rachmiel Levine Diabetes and Obesity Symposium today, Richard Insel, M.D., JDRF’s chief scientific officer, reviewed evidence supporting the need to […]

Bill Woods and the Bionic Pancreas

Photo by Mary Harold.   On Wednesday, November 13th, Bill Woods spoke to a full crowd at Brace Auditorium in the Tully Health Center about his experiences in the Beacon Hill Bionic Pancreas Study. Woods is the Community Manager at Glu, a husband, a father of two, and a diabetic since his youth. During his […]

JDRF-Led Workshop Explores Progress toward an Artificial Pancreas System

Leading experts from industry, academia, and government came together the second week of April in Bethesda, MD, to discuss innovation in the development of an artificial pancreas system at a workshop hosted by the National Institutes of Health, the Food and Drug Administration (FDA), and JDRF. A commercially-viable artificial pancreas system would mimic the biological […]